Regis (RGS) 10-Q2024 Q2 Quarterly report

Filed: 31 Jan 24, 6:07am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Agent, alter, alternative, assumption, assurance, audit, Code, combination, complicate, consent, correspondingly, cumbersome, declared, delay, description, deterring, discourage, discretion, dividend, entitled, Equiniti, fifty, fractional, frequently, Global, growth, holder, interfere, issuable, January, merger, Nasdaq, NOL, occurrence, par, penny, person, Preservation, prevent, prohibited, pursue, qualify, quantitative, regain, retroactively, reverse, seeking, shareholder, sooner, specialist, split, susceptible, suspend, takeover, taxable, tender, tier, Trust, undergo, undergone, underlying, uniformly, viewed, volume

Removed: boxing, freight, guaranteed, large, receipt, reclassified, reducing, translation, unbilled, unrecoverable, white

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated RGS transcripts

RGS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit No. 32

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Regis Corporation (the Registrant) on Form 10-Q for the fiscal quarter ending December 31, 2023 filed with the Securities and Exchange Commission on the date hereof, Matthew Doctor, President and Chief Executive Officer of the Registrant, and Kersten D. Zupfer, Executive Vice President and Chief Financial Officer of the Registrant, each hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Quarterly Report on Form 10-Q complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Registrant.


January 31, 2024

/s/ Matthew Doctor
Matthew Doctor, President and Chief Executive Officer

January 31, 2024

/s/ Kersten D. Zupfer
Kersten D. Zupfer, Executive Vice President and Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.